Latest Breaking News On - Hamad medical corp - Page 8 : comparemela.com

Governor Tom Wolf / Flickr cc Data from three trials posted yesterday show efficacy of the Novavax and Pfizer COVID-19 vaccines and good immune response of the Moderna vaccine against different SARS-CoV-2 variants of concern. Novavax versus B1351 New England Journal of Medicine ( NEJM), the first of which describes a phase 2a-b clinical trial at 16 sites in South Africa from Aug 17 to Nov 25, 2020, on the efficacy of the Novavax COVID-19 vaccine against the B1351 variant first identified in South Africa, where virus transmission is ongoing. Led by scientists from Novavax, the study involved randomly assigning HIV-negative participants aged 18 to 84 years and medically stable HIV-positive participants aged 18 to 64 years in a 1:1 ratio to receive two doses of either the Novavax vaccine or a placebo 21 days apart.

United statesSouth africaUnited kingdomStephane bancelKathleen neuzilUniversity of maryland school medicineHamad medical corpNew england journalWeill cornell medicineHamad medicalMaryland schoolChief executive officer stephane bancelஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்பல்கலைக்கழகம் ஆஃப் மேரிலாந்து பள்ளி மருந்துஹமாத் மருத்துவ கார்ப்